Disruption of MDM2-p53 Interactions by a Small Molecule Inhibitor RG7112 Increases Apoptosis and Impairs Polyploidization of Human Megakaryocytes

被引：1
|
作者：
Iancu-Rubin, Camelia [1 ]
Goar, Mosoyan [1 ]
Hoffman, Ronald [1 ]
机构：
[1] Mt Sinai Sch Med, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1082.1082
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1082
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Design and synthesis of potent, specific and orally active small-molecule inhibitors of the MDM2-p53 interaction
    Yu, Shanghai
    Qin, Dongguang
    Chen, Jianyong
    Wang, Guoping
    Ding, Ke
    Nikolovska-Coleska, Zaneta
    Kumar, Sanjeev
    Qiu, Su
    Bernard, Denzil
    Lu, Yipin
    Kang, Sanmao
    Yang, Daijun
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [32] Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold
    Hardcastle, Ian R.
    Ahmed, Shafiq U.
    Atkins, Helen
    Farnie, Gillian
    Golding, Bernard T.
    Griffin, Roger J.
    Guyenne, Sabrina
    Hutton, Claire
    Kallblad, Per
    Kemp, Stuart J.
    Kitching, Martin S.
    Newell, David R.
    Norbedo, Stefano
    Northen, Julian S.
    Reid, Rebecca J.
    Saravanan, K.
    Willems, Henriette M. G.
    Lunec, John
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) : 6209 - 6221
  • [33] MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
    Azer, Samy A.
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (04):
  • [34] Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
    Koster, R.
    Timmer-Bosscha, H.
    Bischoff, R.
    Gietema, J. A.
    de Jong, S.
    CELL DEATH & DISEASE, 2011, 2 : e148 - e148
  • [35] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
    Zhao, Yujun
    Aguilar, Angelo
    Bernard, Denzil
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1038 - 1052
  • [36] Insight into mechanism of small molecule inhibitors of the MDM2-p53 interaction: Molecular dynamics simulation and free energy analysis
    Chen, Jianzhong
    Wang, Jinan
    Xu, Beisi
    Zhu, Weiliang
    Li, Guohui
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2011, 30 : 46 - 53
  • [37] NOVEL SMALL MOLECULE INHIBITORS OF THE P53-MDM2 /MDM4 INTERACTION FOR INDUCTION OF APOPTOSIS IN AML
    Koehler, L. M.
    Beck, B.
    Huang, H.
    Holak, T.
    Domling, A.
    Subklewe, M.
    HAEMATOLOGICA, 2012, 97 : 259 - 260
  • [38] Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2-p53 signaling
    Xie, Chuhai
    Wu, Boyi
    Chen, Binwei
    Shi, Qunwei
    Guo, Jianhong
    Fan, Ziwen
    Huang, Yan
    ONCOTARGETS AND THERAPY, 2016, 9 : 4005 - 4013
  • [39] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
    Shangary, Sanjeev
    Wang, Shaomeng
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 : 223 - 241
  • [40] Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway
    Bingwu Wang
    Jian Gao
    Zhongjun Zhao
    Xuefei Zhong
    Hao Cui
    Hui Hou
    Yanping Zhang
    Junnian Zheng
    Jiehui Di
    Yong Liu
    Molecular Medicine, 2022, 28
12345